IL206095A0 - Chemically modified factor ix - Google Patents

Chemically modified factor ix

Info

Publication number
IL206095A0
IL206095A0 IL206095A IL20609510A IL206095A0 IL 206095 A0 IL206095 A0 IL 206095A0 IL 206095 A IL206095 A IL 206095A IL 20609510 A IL20609510 A IL 20609510A IL 206095 A0 IL206095 A0 IL 206095A0
Authority
IL
Israel
Prior art keywords
chemically modified
modified factor
factor
chemically
modified
Prior art date
Application number
IL206095A
Other languages
English (en)
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of IL206095A0 publication Critical patent/IL206095A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL206095A 2007-12-27 2010-05-31 Chemically modified factor ix IL206095A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US926307P 2007-12-27 2007-12-27
PCT/EP2008/010925 WO2009083187A1 (en) 2007-12-27 2008-12-19 Chemically modified factor ix

Publications (1)

Publication Number Publication Date
IL206095A0 true IL206095A0 (en) 2010-11-30

Family

ID=40344940

Family Applications (1)

Application Number Title Priority Date Filing Date
IL206095A IL206095A0 (en) 2007-12-27 2010-05-31 Chemically modified factor ix

Country Status (11)

Country Link
US (2) US20090176708A1 (https=)
EP (4) EP2568041A1 (https=)
JP (1) JP2011507919A (https=)
KR (1) KR20100110799A (https=)
CN (1) CN101952422A (https=)
AU (1) AU2008342260B2 (https=)
CA (1) CA2709960A1 (https=)
IL (1) IL206095A0 (https=)
NZ (3) NZ598193A (https=)
RU (1) RU2010131189A (https=)
WO (1) WO2009083187A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2353588B1 (en) 2010-01-21 2015-04-15 Agricultural Technology Research Institute A sustained release preparation of factor IX
AR095527A1 (es) 2013-03-15 2015-10-21 Biogen Idec Inc Formulaciones de polipéptido fc-factor ix
AR099340A1 (es) * 2014-02-12 2016-07-13 Novo Nordisk As Conjugados del factor de coagulación ix
EA202092926A3 (ru) 2014-03-24 2021-10-29 Биовератив Терапьютикс Инк. Лиофилизированные составы, содержащие фактор ix
CN114729317A (zh) 2019-11-29 2022-07-08 新泽西鲁特格斯州立大学 脐带血血浆制品、组织和细胞外泌体的分离方法，其组合物及使用方法
CN114786481A (zh) * 2019-11-29 2022-07-22 新泽西鲁特格斯州立大学 用于储存血液制品的组合物、试剂盒和方法及其使用方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS538750B2 (https=) 1971-08-18 1978-03-31
AT348548B (de) 1977-04-08 1979-02-26 Laevosan Gmbh & Co Kg Verfahren zur herstellung von alsblutplasma- expander geeignerter hydroxyaethylstaerke
US5614500A (en) * 1983-03-04 1997-03-25 The Scripps Research Institute Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography
DE3313600A1 (de) 1983-04-14 1984-10-18 Laevosan-Gesellschaft mbH & Co. KG, Linz Plasmastreckmittel auf staerkebasis und verfahren zu ihrer herstellung
DE19975071I2 (de) 1989-06-16 2000-02-03 Fresenius Ag Hydroxyethylstaerke als Plasmaexpander Verfahren zu ihrer Herstellung und Verwendung als kolloidales Plasmaersatzmittel
FR2702160B1 (fr) 1993-03-02 1995-06-02 Biovecteurs As Vecteurs particulaires synthétiques et procédé de préparation.
DE4310974C2 (de) 1993-04-03 1996-08-01 Fresenius Ag Verwendung von Hydroxyethylstärke zur Verbesserung der Mikrozirkulation
FR2704145B1 (fr) 1993-04-21 1995-07-21 Pasteur Institut Vecteur particulaire et composition pharmaceutique le contenant.
US5621039A (en) * 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
FR2723849B1 (fr) 1994-08-31 1997-04-11 Biovector Therapeutics Sa Procede pour augmenter l'immunogenicite, produit obtenu et composition pharmaceutique
BR9807936A (pt) * 1997-04-08 2000-02-22 Baxter Ag Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação
US7179617B2 (en) * 2001-10-10 2007-02-20 Neose Technologies, Inc. Factor IX: remolding and glycoconjugation of Factor IX
CA2521784C (en) 2003-04-08 2012-03-27 Yeda Research And Development Co. Ltd. Reversible pegylated drugs
WO2005014655A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
AU2004296860B2 (en) * 2003-12-03 2010-04-22 Novo Nordisk A/S Glycopegylated factor IX
US20060040856A1 (en) * 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
DE502005001896D1 (en) 2004-03-01 2007-12-20 Braun Melsungen Ag Hydroxyethylstärke
TWI417303B (zh) * 2004-03-11 2013-12-01 Fresenius Kabi De Gmbh 經由還原胺化作用製得之羥烷基澱粉及蛋白質的接合物
ATE469216T1 (de) * 2004-08-17 2010-06-15 Csl Behring Gmbh Modifizierte vitamin-k-abhängige polypeptide
AU2006222187A1 (en) * 2005-03-11 2006-09-14 Fresenius Kabi Deutschland Gmbh Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch
US7375084B2 (en) * 2006-03-07 2008-05-20 Baxter International Inc. Highly phosphorylated and sulfated recombinant factor IX
EP1999097B1 (en) 2006-03-29 2011-12-21 DSM IP Assets B.V. Curcumin synthesis
EP2423305A1 (en) * 2006-06-19 2012-02-29 Catalyst Biosciences, Inc. Modified coagulation factor IX polypeptides and use thereof for treatment
CA2689557C (en) * 2007-06-15 2018-08-14 National Research Council Of Canada Engineered versions of polysialyltransferases with enhanced enzymatic properties

Also Published As

Publication number Publication date
EP2247723A1 (en) 2010-11-10
EP2568041A1 (en) 2013-03-13
EP2568043A1 (en) 2013-03-13
AU2008342260A1 (en) 2009-07-09
KR20100110799A (ko) 2010-10-13
WO2009083187A8 (en) 2009-09-17
CN101952422A (zh) 2011-01-19
US20090176708A1 (en) 2009-07-09
WO2009083187A1 (en) 2009-07-09
AU2008342260B2 (en) 2013-10-17
CA2709960A1 (en) 2009-07-09
RU2010131189A (ru) 2012-02-10
NZ603997A (en) 2013-02-22
JP2011507919A (ja) 2011-03-10
NZ585835A (en) 2012-07-27
EP2568042A1 (en) 2013-03-13
US20120177625A1 (en) 2012-07-12
NZ598193A (en) 2012-12-21

Similar Documents

Publication Publication Date Title
GB0700580D0 (en) Use
GB0702456D0 (en) New combination
AP2010005314A0 (en) Nanodispersian
GB0714670D0 (en) Use
GB0712503D0 (en) Use
GB0702385D0 (en) New combination
GB0702416D0 (en) New combination
IL206095A0 (en) Chemically modified factor ix
GB0701437D0 (en) Electro-chlorinator
GB0700595D0 (en) Holecutter
DE602008004135D1 (en) Triphenylmethan- und xanthenpigmente
GB0701096D0 (en) Use
AU3952P (en) FLOCHRDEF Chrysocephalum apiculatum
AU3606P (en) Jaywick xTriticosecale
AU3702P (en) DarwinGold Dianella ensifolia
AU3642P (en) TAS100 Dianella tasmanica
AU3613P (en) LS005A01 Leucospermum cuneiforme
AU3595P (en) Goldust Strobilanthes anisophyllus
GB0701006D0 (en) Blankie bear
GB0724285D0 (en) New uses
GB0710085D0 (en) I
GB0723723D0 (en) Use
GB0714155D0 (en) use
GB0708021D0 (en) Use
AU316644S (en) Bed - AP